Page last updated: 2024-10-25

clofibrate and Porphyrias

clofibrate has been researched along with Porphyrias in 1 studies

angiokapsul: contains clofibrate & insoitolnicotinate

Porphyrias: A diverse group of metabolic diseases characterized by errors in the biosynthetic pathway of HEME in the LIVER, the BONE MARROW, or both. They are classified by the deficiency of specific enzymes, the tissue site of enzyme defect, or the clinical features that include neurological (acute) or cutaneous (skin lesions). Porphyrias can be hereditary or acquired as a result of toxicity to the hepatic or erythropoietic marrow tissues.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stejskal, R1
Itabashi, M1
Stanek, J1
Hruban, Z1

Other Studies

1 other study available for clofibrate and Porphyrias

ArticleYear
Experimental porphyria induced by 3-(2,4,6-trimethylphenyl)-thioethyl)-4 methylsydnone.
    Virchows Archiv. B, Cell pathology, 1975, Volume: 18, Issue:2

    Topics: Alcohol Oxidoreductases; Animals; Bile Ducts, Intrahepatic; Body Weight; Catalase; Chemical and Drug

1975